These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 10739257)

  • 1. Apoflavodoxin (un)folding followed at the residue level by NMR.
    van Mierlo CP; van den Oever JM; Steensma E
    Protein Sci; 2000 Jan; 9(1):145-57. PubMed ID: 10739257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The equilibrium unfolding of Azotobacter vinelandii apoflavodoxin II occurs via a relatively stable folding intermediate.
    van Mierlo CP; van Dongen WM; Vergeldt F; van Berkel WJ; Steensma E
    Protein Sci; 1998 Nov; 7(11):2331-44. PubMed ID: 9827999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noncooperative Formation of the off-pathway molten globule during folding of the alpha-beta parallel protein apoflavodoxin.
    Nabuurs SM; Westphal AH; van Mierlo CP
    J Am Chem Soc; 2009 Feb; 131(7):2739-46. PubMed ID: 19170491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of on- and off-pathway intermediates in the folding kinetics of Azotobacter vinelandii apoflavodoxin.
    Bollen YJ; Sánchez IE; van Mierlo CP
    Biochemistry; 2004 Aug; 43(32):10475-89. PubMed ID: 15301546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extensive formation of off-pathway species during folding of an alpha-beta parallel protein is due to docking of (non)native structure elements in unfolded molecules.
    Nabuurs SM; Westphal AH; van Mierlo CP
    J Am Chem Soc; 2008 Dec; 130(50):16914-20. PubMed ID: 19053416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A general approach for detecting folding intermediates from steady-state and time-resolved fluorescence of single-tryptophan-containing proteins.
    Laptenok SP; Visser NV; Engel R; Westphal AH; van Hoek A; van Mierlo CP; van Stokkum IH; van Amerongen H; Visser AJ
    Biochemistry; 2011 May; 50(17):3441-50. PubMed ID: 21425856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein folding and stability investigated by fluorescence, circular dichroism (CD), and nuclear magnetic resonance (NMR) spectroscopy: the flavodoxin story.
    van Mierlo CP; Steensma E
    J Biotechnol; 2000 May; 79(3):281-98. PubMed ID: 10867188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural characterisation of apoflavodoxin shows that the location of the stable nucleus differs among proteins with a flavodoxin-like topology.
    Steensma E; van Mierlo CP
    J Mol Biol; 1998 Sep; 282(3):653-66. PubMed ID: 9737928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equilibrium and kinetics of the folding of equine lysozyme studied by circular dichroism spectroscopy.
    Mizuguchi M; Arai M; Ke Y; Nitta K; Kuwajima K
    J Mol Biol; 1998; 283(1):265-77. PubMed ID: 9761689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cooperative stabilization of a molten globule apoflavodoxin fragment.
    Maldonado S; Jiménez MA; Langdon GM; Sancho J
    Biochemistry; 1998 Jul; 37(30):10589-96. PubMed ID: 9692948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Native hydrogen bonds in a molten globule: the apoflavodoxin thermal intermediate.
    Irún MP; Garcia-Mira MM; Sanchez-Ruiz JM; Sancho J
    J Mol Biol; 2001 Mar; 306(4):877-88. PubMed ID: 11243795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of stable protein folding intermediates by equilibrium phi-analysis: the apoflavodoxin thermal intermediate.
    Campos LA; Bueno M; Lopez-Llano J; Jiménez MA; Sancho J
    J Mol Biol; 2004 Nov; 344(1):239-55. PubMed ID: 15504414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Last in, first out: the role of cofactor binding in flavodoxin folding.
    Bollen YJ; Nabuurs SM; van Berkel WJ; van Mierlo CP
    J Biol Chem; 2005 Mar; 280(9):7836-44. PubMed ID: 15632150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the folding and unfolding reactions of a small beta-barrel protein of novel topology, the MTCP1 oncogene product P13.
    Roumestand C; Boyer M; Guignard L; Barthe P; Royer CA
    J Mol Biol; 2001 Sep; 312(1):247-59. PubMed ID: 11545600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational stability of apoflavodoxin.
    Genzor CG; Beldarraín A; Gómez-Moreno C; López-Lacomba JL; Cortijo M; Sancho J
    Protein Sci; 1996 Jul; 5(7):1376-88. PubMed ID: 8819170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Illuminating the off-pathway nature of the molten globule folding intermediate of an α-β parallel protein.
    Lindhoud S; Westphal AH; Borst JW; van Mierlo CP
    PLoS One; 2012; 7(9):e45746. PubMed ID: 23029219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macromolecular crowding compacts unfolded apoflavodoxin and causes severe aggregation of the off-pathway intermediate during apoflavodoxin folding.
    Engel R; Westphal AH; Huberts DHEW; Nabuurs SM; Lindhoud S; Visser AJWG; van Mierlo CPM
    J Biol Chem; 2008 Oct; 283(41):27383-27394. PubMed ID: 18640986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folding of horse cytochrome c in the reduced state.
    Bhuyan AK; Udgaonkar JB
    J Mol Biol; 2001 Oct; 312(5):1135-60. PubMed ID: 11580255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do proteins with similar folds have similar transition state structures? A diffuse transition state of the 169 residue apoflavodoxin.
    Bueno M; Ayuso-Tejedor S; Sancho J
    J Mol Biol; 2006 Jun; 359(3):813-24. PubMed ID: 16647718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural analysis of an equilibrium folding intermediate in the apoflavodoxin native ensemble by small-angle X-ray scattering.
    Ayuso-Tejedor S; García-Fandiño R; Orozco M; Sancho J; Bernadó P
    J Mol Biol; 2011 Mar; 406(4):604-19. PubMed ID: 21216251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.